Wanbury Ltd Quarterly Results
Q4 FY24-25 Results Summary
Revenue
The revenue stands at ₹172.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.89 per cent from ₹133.45 crore. This corresponds to a year-on-year *(YoY) growth of 23.38 per cent.
Operating Profit
Operating Profit stands at ₹29.63 crore, reflecting a quarter-on-quarter *(QoQ) increase of 112.55 per cent from ₹13.94 crore. This corresponds to a year-on-year *(YoY) growth of 63.07 per cent.
PBDT
PBDT stands at ₹22.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 386.55 per cent from ₹4.61 crore. This corresponds to a year-on-year *(YoY) decline of 39.67 per cent.
Profit Before Tax
Profit Before Tax stands at ₹19.06 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,377.52 per cent from ₹1.29 crore. This corresponds to a year-on-year *(YoY) decline of 43.78 per cent.
Net Profit
Net Profit stands at ₹20.26 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,560.66 per cent from ₹1.22 crore. This represents a 39.76 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Wanbury Ltd Earnings
- YOY
- QOQ
Wanbury Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Wanbury Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Wanbury Ltd Financial Reports
Wanbury Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Wanbury | 0.92% | 10.83% | 9.72% | 8.59% | 19.40% | -0.70% |
| Shukra Pharma. | -4.13% | -4.42% | -6.81% | -27.64% | -25.14% | 118.54% |
| Ind-Swift Labs. | -2.33% | -1.86% | -2.01% | -11.05% | 37.73% | 74.47% |
| Bajaj Healthcare | 0.31% | 5.62% | -8.33% | -7.79% | -28.24% | -49.32% |
| Bharat Parenter. | 2.90% | 10.88% | 12.76% | 25.58% | 25.02% | 21.29% |
| Themis Medicare | 1.34% | 3.37% | 3.21% | 15.59% | -6.39% | -28.28% |
| Fermenta Biotec. | -0.18% | 2.96% | -3.69% | -8.96% | 6.27% | 0.88% |
Company Info
Company Information
E D & Wholetime Director : K Chandran
WTD & Executive Director : Mohan Kumar Rayana
Independent Non Exe. Director : Anupam Vaidya
Independent Non Exe. Director : Mridul Sumanlal Mehta
Independent Non Exe. Director : MANOJKUMAR KHUBCHAND GURSAHANI
Independent Non Exe. Director : Pallavur Sankar Dass Vaidyanathan
Company Sec. & Compli. Officer : Jitendra J Gandhi